www.fdanews.com/articles/188999-rps-diagnostics-gains-updated-ce-mark-for-rpc-test
![ClearanceStamp_Blue.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Blue.gif?t=1576043968&width=430)
RPS Diagnostics Gains Updated CE Mark for RPC Test
October 31, 2018
RPS Diagnostics’ FebriDx, a rapid point-of-care test, has received an updated CE Mark, clearing it for launch in the EU.
The diagnostic test allows for a 10-minute assessment of the patient’s immune response to an acute respiratory infection by analyzing a fingerstick blood sample.
The single-use device points out underlying, clinically significant infections in patients and determines if they are bacterial or viral.